Literature DB >> 8688968

Expression of CD44 splice variants in human skin and epidermal tumours.

S Seiter1, W Tilgen, K Herrmann, D Schadendorf, E Patzelt, P Möller, M Zöller.   

Abstract

Splice variants of the adhesion molecule CD44 (CD44v) are important in the lymphatic spread of rat carcinoma cells. In several human tumours expression of CD44v correlates with tumour progression. However, little is known about the physiological functions of distinct variant exons. Here we report on the immunohistological evaluation of CD44 expression in normal human skin and epidermal tumours which do not metastasise, or do so vary rarely. Frozen tissues were stained with a panel of monoclonal antibodies, recognizing epitopes of the CD44 standard isoform, as well as of variant exons v5, v6, v7, v7-v8 and v10. Stratum basale and spinosum as well as the root shaft of hairs reacted strongly with the whole panel of anti-CD44 antibodies. Stratum corneum, acinar cells of sebaceous and eccrine sweat glands stained with anti-CD44v5, anti-CD44v6 and anti-CD44v7, but not with anti-CD44v10, the latter recognizing the "epithelial isoform" (CD44v8-v10) of CD44. Ductal cells of glands and apocrine glands did not express CD44v. Compared with its expression in normal human skin, CD44v expression was reduced in basal cell carcinoma and squamous cell carcinoma of the skin. This was particularly true of CD44v10. The expression of CD44v in normal skin and dermal appendages indicates that not all combinations of variant exons are involved in tumour progression. Since the epithelial isoform is particularly downregulated in basal cell carcinoma and squamous cell carcinoma of the skin, it is unlikely that exons v8-v10 play a role in tumour progression. Rather, they may be of functional importance in maintenance of the epidermal structure.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8688968     DOI: 10.1007/bf00200656

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  56 in total

1.  A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in man.

Authors:  S T Jalkanen; R F Bargatze; L R Herron; E C Butcher
Journal:  Eur J Immunol       Date:  1986-10       Impact factor: 5.532

2.  Isolation and DNA sequence of a cDNA clone encoding a lymphocyte adhesion receptor for high endothelium.

Authors:  R L Idzerda; W G Carter; C Nottenburg; E A Wayner; W M Gallatin; T St John
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

3.  Cylindroma expresses immunohistochemical markers linking it to eccrine coil.

Authors:  N S Penneys; M Kaiser
Journal:  J Cutan Pathol       Date:  1993-02       Impact factor: 1.587

4.  Expression of CD44 is repressed in neuroblastoma cells.

Authors:  E Shtivelman; J M Bishop
Journal:  Mol Cell Biol       Date:  1991-11       Impact factor: 4.272

Review 5.  Are CD44 variant isoforms involved in human tumour progression?

Authors:  U Günthert; R Stauder; B Mayer; H J Terpe; L Finke; K Friedrichs
Journal:  Cancer Surv       Date:  1995

6.  Murine cell surface glycoproteins. Purification of the polymorphic Pgp-1 antigen and analysis of its expression on macrophages and other myeloid cells.

Authors:  E N Hughes; A Colombatti; J T August
Journal:  J Biol Chem       Date:  1983-01-25       Impact factor: 5.157

Review 7.  CD44: physiological expression of distinct isoforms as evidence for organ-specific metastasis formation.

Authors:  M Zöller
Journal:  J Mol Med (Berl)       Date:  1995-09       Impact factor: 4.599

8.  Participation in normal immune responses of a metastasis-inducing splice variant of CD44.

Authors:  R Arch; K Wirth; M Hofmann; H Ponta; S Matzku; P Herrlich; M Zöller
Journal:  Science       Date:  1992-07-31       Impact factor: 47.728

9.  Post-translational protein modification and expression of ankyrin-binding site(s) in GP85 (Pgp-1/CD44) and its biosynthetic precursors during T-lymphoma membrane biosynthesis.

Authors:  V B Lokeshwar; L Y Bourguignon
Journal:  J Biol Chem       Date:  1991-09-25       Impact factor: 5.157

10.  Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin.

Authors:  M Salmi; K Grön-Virta; P Sointu; R Grenman; H Kalimo; S Jalkanen
Journal:  J Cell Biol       Date:  1993-07       Impact factor: 10.539

View more
  11 in total

Review 1.  CD44 in inflammation and metastasis.

Authors:  J Lesley; R Hyman; N English; J B Catterall; G A Turner
Journal:  Glycoconj J       Date:  1997-08       Impact factor: 2.916

2.  Identification of specific chondroitin sulfate species in cutaneous autoimmune disease.

Authors:  Jessica S Kim; Victoria P Werth
Journal:  J Histochem Cytochem       Date:  2011-08       Impact factor: 2.479

3.  In vivo efficacy of nano hyaluronan-conjugated cisplatin for treatment of murine melanoma.

Authors:  Qiuhong Yang; Daniel J Aires; Shuang Cai; Garth R Fraga; Da Zhang; Cicy Z Li; M Laird Forrest
Journal:  J Drugs Dermatol       Date:  2014-03       Impact factor: 2.114

4.  Gottron's papules exhibit dermal accumulation of CD44 variant 7 (CD44v7) and its binding partner osteopontin: a unique molecular signature.

Authors:  Jessica S Kim; Muhammad M Bashir; Victoria P Werth
Journal:  J Invest Dermatol       Date:  2012-03-29       Impact factor: 8.551

5.  Melanoma cells undergo aggressive coalescence in a 3D Matrigel model that is repressed by anti-CD44.

Authors:  Deborah Wessels; Daniel F Lusche; Edward Voss; Spencer Kuhl; Emma C Buchele; Michael R Klemme; Kanoe B Russell; Joseph Ambrose; Benjamin A Soll; Aaron Bossler; Mohammed Milhem; Charles Goldman; David R Soll
Journal:  PLoS One       Date:  2017-03-06       Impact factor: 3.240

6.  Up-regulation of CD44 variant exon expression in endometrial carcinomas: analysis of mRNA and protein isoforms, and relation to clinicopathological factors.

Authors:  M Saegusa; I Okayasu
Journal:  Jpn J Cancer Res       Date:  1998-03

7.  Overexpression of CD44 Variant 9: A Novel Cancer Stem Cell Marker in Human Cholangiocarcinoma in Relation to Inflammation.

Authors:  Nattawan Suwannakul; Ning Ma; Raynoo Thanan; Somchai Pinlaor; Piti Ungarreevittaya; Kaoru Midorikawa; Yusuke Hiraku; Shinji Oikawa; Shosuke Kawanishi; Mariko Murata
Journal:  Mediators Inflamm       Date:  2018-10-09       Impact factor: 4.711

8.  Demonstration of a melanoma-specific CD44 alternative splicing pattern that remains qualitatively stable, but shows quantitative changes during tumour progression.

Authors:  Livia Raso-Barnett; Balazs Banky; Tamas Barbai; Peter Becsagh; Jozsef Timar; Erzsebet Raso
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

9.  Isolation of All CD44 Transcripts in Human Epidermis and Regulation of Their Expression by Various Agents.

Authors:  Kwesi Teye; Sanae Numata; Norito Ishii; Rafal P Krol; Atsunari Tsuchisaka; Takahiro Hamada; Hiroshi Koga; Tadashi Karashima; Chika Ohata; Daisuke Tsuruta; Hideyuki Saya; Marek Haftek; Takashi Hashimoto
Journal:  PLoS One       Date:  2016-08-09       Impact factor: 3.240

Review 10.  Oncogenic alternative splicing switches: role in cancer progression and prospects for therapy.

Authors:  Serena Bonomi; Stefania Gallo; Morena Catillo; Daniela Pignataro; Giuseppe Biamonti; Claudia Ghigna
Journal:  Int J Cell Biol       Date:  2013-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.